CU Medical Systems
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
CU Medical Systems makes automated external defibrillators (AEDs), portable devices that deliver an electric shock to restart a heart beating dangerously out of rhythm.
Its customers include hospitals, fire stations, public agencies, residential buildings, and corporations, both in South Korea and internationally. Listed on KOSDAQ, South Korea's tech and small-cap board, the company's entire product portfolio centres on AEDs and related emergency medical equipment, with overseas subsidiaries in Germany and Japan supporting international distribution.
Summary is AI-generated and may contain errors · figures from DART filings
The company has established local subsidiaries in Germany and Japan to handle marketing, sales, and after-sales support in those markets directly.
CU Medical Systems in five facts
What does CU Medical Systems do?
CU Medical Systems makes automated external defibrillators (AEDs), portable devices that deliver an electric shock to restart a heart beating dangerously out of rhythm.
Where is CU Medical Systems listed and in which sector?
CU Medical Systems (Korean name: 씨유메디칼) trades under KRX code 115480 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is CU Medical Systems?
Its market capitalisation was US$19.1M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were CU Medical Systems's latest annual revenue and operating profit?
For fiscal year 2025, CU Medical Systems reported revenue of US$36.4M, operating profit of US$8.2M and net income of US$618.3K, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 18.7% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Conversion price adjustmentAug 31
- Material event report (decision to redeem own convertible bonds early)
CU Medical Systems decided on July 6, 2026 to redeem US$1.31M in face value of its Series 11 convertible bonds before maturity for US$1.35M, exercising a call option, leaving US$3.27M in face value outstanding out of the original US$4.58M issue.
Capital raise · Jul 6 - Change of largest shareholder of the nominee entity that is the largest shareholderOwnership change · Apr 30
- Trading suspension (share consolidation/split registration)M&A · Apr 21
- Material event report (convertible bonds)
CU Medical Systems disclosed convertible bonds to raise US$4.71M, about 25.2% of its market value.
Capital raise · Mar 18 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
CU Medical Systems reported consolidated results for FY2025: revenue of US$33.5M (+18.6% year on year), operating profit of US$7.51M (+38.6% year on year) and net income of US$458K (from a loss a year earlier).
Earnings · Feb 25 - [Amended] Material event report (equity acquisition)M&A · Jan 20